APA (7th ed.) Citation

Ma, B., Yang, K., Li, X., Su, N., Yu, T., Zou, Y., . . . Zhang, L. (2024). Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy. Therapeutic drug monitoring, 46(4), 503. https://doi.org/10.1097/FTD.0000000000001180

Chicago Style (17th ed.) Citation

Ma, Bingsuo, et al. "Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy." Therapeutic Drug Monitoring 46, no. 4 (2024): 503. https://doi.org/10.1097/FTD.0000000000001180.

MLA (9th ed.) Citation

Ma, Bingsuo, et al. "Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy." Therapeutic Drug Monitoring, vol. 46, no. 4, 2024, p. 503, https://doi.org/10.1097/FTD.0000000000001180.